Literature DB >> 2217500

Antagonism of cocaine, amphetamine, and methamphetamine toxicity.

R W Derlet1, T E Albertson, P Rice.   

Abstract

The effect of diazepam, haloperidol, MK-801, and propranolol in antagonizing behavioral symptoms induced by lethal doses of cocaine, amphetamine, and methamphetamine were studied in a rat model. Animals were first pretreated IP with potential antagonists, diazepam (2, 5, and 10 mg/kg), haloperidol (5, 10, and 20 mg/kg), propranolol (5, 10, and 20 mg/kg), MK-801 (0.5, 1.0, and 2.5 mg/kg), and then were challenged IP with cocaine (70 mg/kg) (LD85), d-amphetamine (75 mg/kg) (LD100), and methamphetamine (100 mg/kg) (LD90). Diazepam, at all doses, provided significant protection against cocaine- (p less than or equal to 0.01) and methamphetamine- (p less than or equal to 0.05) induced seizures and produced a dose-dependent effect against amphetamine-induced seizures. MK-801, at all doses, reduced seizures in all groups (p less than or equal to 0.01). Propranolol altered the incidence of methamphetamine-induced seizures. Significant protection against cocaine-induced death was afforded by diazepam (p less than or equal to 0.01) and propranolol (p less than or equal to 0.05). Significant protection against amphetamine-induced death was provided by haloperidol (all doses, p less than or equal to 0.1), MK-801 (all doses, p less than or equal to 0.1), and propranolol (10 and 20 mg/kg, p less than or equal to 0.1). No agent reduced the incidence of methamphetamine- (50 or 100 mg/kg) induced death. The failure of d-amphetamine antagonists to protect against methamphetamine-induced toxicity and death suggest that different mechanisms of toxicity may exist between these drugs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2217500     DOI: 10.1016/0091-3057(90)90071-o

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  11 in total

1.  The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access.

Authors:  Laura Orio; Sunmee Wee; Amy H Newman; Luigi Pulvirenti; George F Koob
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

2.  The effect of olanzapine pretreatment on acute cocaine toxicity in mice.

Authors:  Kennon J Heard; Nathan R Cleveland; Shay Krier
Journal:  Clin Toxicol (Phila)       Date:  2009-07       Impact factor: 4.467

3.  Mechanisms of acute cocaine toxicity.

Authors:  Kennon Heard; Robert Palmer; Nancy R Zahniser
Journal:  Open Pharmacol J       Date:  2008

4.  cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum.

Authors:  M Andersson; C Konradi; M A Cenci
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

5.  M100907 and BD 1047 attenuate the acute toxic effects of methamphetamine.

Authors:  Azizi Ray; Clinton E Canal; J Christopher Ehlen; Kenner C Rice; Kevin Sean Murnane
Journal:  Neurotoxicology       Date:  2019-06-01       Impact factor: 4.294

6.  Administration of ziprasidone for 10 days increases cocaine toxicity in mice.

Authors:  K Heard; S Krier; N R Zahniser
Journal:  Hum Exp Toxicol       Date:  2008-06       Impact factor: 2.903

7.  Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat: an experimental study using light and electron microscopy.

Authors:  Hari S Sharma; Eugene A Kiyatkin
Journal:  J Chem Neuroanat       Date:  2008-08-19       Impact factor: 3.052

Review 8.  Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management.

Authors:  Henry A Spiller; Hannah L Hays; Alfred Aleguas
Journal:  CNS Drugs       Date:  2013-07       Impact factor: 5.749

9.  Safety of intravenous methamphetamine administration during treatment with bupropion.

Authors:  Thomas F Newton; John D Roache; Richard De La Garza; Tim Fong; Christopher L Wallace; Shou-Hua Li; Ahmed Elkashef; Nora Chiang; Roberta Kahn
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.415

10.  Behavioral effects of ketamine and toxic interactions with psychostimulants.

Authors:  Tamaki Hayase; Yoshiko Yamamoto; Keiichi Yamamoto
Journal:  BMC Neurosci       Date:  2006-03-16       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.